Literature DB >> 33390046

Aortic Pulse Wave Velocity Predicts Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography: A Comparison of Invasive Measurements and Noninvasive Estimates.

Bernhard Hametner1, Siegfried Wassertheurer1, Christopher Clemens Mayer1, Kathrin Danninger2, Ronald K Binder2, Thomas Weber2.   

Abstract

Aortic pulse wave velocity (PWV) is directly related to arterial stiffness. Different methods for the determination of PWV coexist. The aim of this prospective study was to evaluate the prognostic value of PWV in high-risk patients with suspected coronary artery disease undergoing invasive angiography and to compare 3 different methods for assessing PWV. In 1040 patients, invasive PWV (iPWV) was measured during catheter pullback. Additionally, PWV was estimated with a model incorporating age, central systolic blood pressure, and pulse waveform characteristics obtained from noninvasive measurements (estimated PWV). As a third method, PWV was calculated with a formula solely based on age and blood pressure (formula-based PWV). Survival analysis was based on continuous PWV as well as using cutoff values. After a median follow-up duration of 1565 days, 24% of the patients reached the combined end point (cardiovascular events or mortality). Cox proportional hazard ratios per 1 SD were 1.35 for iPWV, 1.37 for estimated PWV, and 1.28 for formula-based PWV (P<0.0001 for all 3 methods) in univariate analysis, remaining statistically significant after comprehensive multivariable adjustments. In a model including a modified risk score for coronary artery disease, iPWV and estimated PWV remained borderline significant. The net reclassification improvement was significant for iPWV (0.173), formula-based PWV (0.181), and estimated PWV (0.230). All 3 methods for the determination of PWV predicted cardiovascular events and mortality in patients with suspected coronary artery disease. This indicates that iPWV as well as both noninvasive estimation methods are suitable for the assessment of arterial stiffness, bearing in mind their individual characteristics.

Entities:  

Keywords:  angiography; aorta; arteries; blood pressure; coronary artery disease

Year:  2021        PMID: 33390046     DOI: 10.1161/HYPERTENSIONAHA.120.15336

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Estimated Pulse Wave Velocity Is Associated With All-Cause Mortality During 8.5 Years Follow-up in Patients Undergoing Elective Coronary Angiography.

Authors:  Esben Laugesen; Kevin K W Olesen; Christian Daugaard Peters; Niels Henrik Buus; Michael Maeng; Hans Erik Botker; Per L Poulsen
Journal:  J Am Heart Assoc       Date:  2022-05-10       Impact factor: 6.106

Review 2.  Metabolomics of Arterial Stiffness.

Authors:  Kaido Paapstel; Jaak Kals
Journal:  Metabolites       Date:  2022-04-20

3.  Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study.

Authors:  Sangeetha Nathaniel; Shane McGinty; Melissa A H Witman; David G Edwards; William B Farquhar; Vinay Hosmane; Megan M Wenner
Journal:  Physiol Rep       Date:  2022-03

4.  Evaluation of Cardiac Function of Pregnant Women with High Blood Pressure during Gestation Period and Coupling of Hearts with Peripheral Vessels by Ultrasonic Cardiogram under Artificial Intelligence Algorithm.

Authors:  Xia Zhang; Xi Liang; Wen Cao
Journal:  Comput Math Methods Med       Date:  2022-01-27       Impact factor: 2.238

5.  Utility of estimated pulse wave velocity for assessing vascular stiffness: comparison of methods.

Authors:  Stefan Möstl; Fabian Hoffmann; Jan-Niklas Hönemann; Jose Ramon Alvero-Cruz; Jörn Rittweger; Jens Tank; Jens Jordan
Journal:  Elife       Date:  2022-05-03       Impact factor: 8.713

6.  Pulse wave velocity in South African women and children: comparison between the Mobil-O-Graph and SphygmoCor XCEL devices.

Authors:  Andrea Kolkenbeck-Ruh; Larske Marit Soepnel; Andrew Wooyoung Kim; Sanushka Naidoo; Wayne Smith; Justine Davies; Lisa Jayne Ware
Journal:  J Hypertens       Date:  2022-01-01       Impact factor: 4.844

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.